Literature DB >> 31735561

Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials.

Gwyneth Davies1, Nicola J Rowbotham2, Sherie Smith2, Zoe C Elliot3, Katie Gathercole4, Oli Rayner5, Paul A Leighton6, Sophie Herbert2, Alistair Ja Duff7, Suja Chandran8, Tracey Daniels9, Edward F Nash10, Alan R Smyth2.   

Abstract

In a recent James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF) the top priority clinical research question was: "What are effective ways of simplifying the treatment burden of people with CF?" We aimed to summarise the lived experience of treatment burden and suggest research themes aimed at reducing it. An online questionnaire was co-produced and responses subjected to quantitative and thematic analysis. 941 survey responses were received (641 from lay community). People with CF reported a median of 10 (interquartile range: 6-15) current treatments. Seven main themes relating to simplifying treatment burden were identified. Treatment burden is high, extending beyond time taken to perform routine daily treatments, with impact varying according to person-specific factors. Approaches to communication, support, evaluation of current treatments, service set-up, and treatment logistics (obtaining/administration) contribute to burden, offering scope for evaluation in clinical trials or service improvement.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical trial; Co-production; Cystic fibrosis; Priority setting; Treatment burden

Year:  2019        PMID: 31735561     DOI: 10.1016/j.jcf.2019.10.025

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  13 in total

Review 1.  An Update on CFTR Modulators as New Therapies for Cystic Fibrosis.

Authors:  John A King; Anna-Louise Nichols; Sian Bentley; Siobhan B Carr; Jane C Davies
Journal:  Paediatr Drugs       Date:  2022-05-16       Impact factor: 3.022

Review 2.  Short-acting inhaled bronchodilators for cystic fibrosis.

Authors:  Sherie Smith; Nicola J Rowbotham; Christopher T Edwards
Journal:  Cochrane Database Syst Rev       Date:  2022-06-24

Review 3.  Physical activity and exercise training in cystic fibrosis.

Authors:  Thomas Radtke; Sherie Smith; Sarah J Nevitt; Helge Hebestreit; Susi Kriemler
Journal:  Cochrane Database Syst Rev       Date:  2022-08-09

Review 4.  Family-building and parenting considerations for people with cystic fibrosis.

Authors:  Traci M Kazmerski; Natalie E West; Raksha Jain; Ahmet Uluer; Anna M Georgiopoulos; Moira L Aitken; Jennifer L Taylor-Cousar
Journal:  Pediatr Pulmonol       Date:  2021-08-18

Review 5.  Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes.

Authors:  Aileen Toner; Anna McCloy; Paula Dyce; Dilip Nazareth; Freddy Frost
Journal:  Cochrane Database Syst Rev       Date:  2021-11-29

6.  Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?

Authors:  Emily Granger; Gwyneth Davies; Ruth H Keogh
Journal:  J Cyst Fibros       Date:  2021-09-06       Impact factor: 5.527

7.  Protocol for Project Fizzyo, an analytic longitudinal observational cohort study of physiotherapy for children and young people with cystic fibrosis, with interrupted time-series design.

Authors:  Emma Raywood; Helen Douglas; Kunal Kapoor; Nicole Filipow; Nicky Murray; Rachel O'Connor; Lee Stott; Greg Saul; Tim Kuzhagaliyev; Gwyneth Davies; Olga Liakhovich; Tempest Van Schaik; Bianca Furtuna; John Booth; Harriet Shannon; Mandy Bryon; Eleanor Main
Journal:  BMJ Open       Date:  2020-10-07       Impact factor: 2.692

Review 8.  Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data.

Authors:  Pieter-Jan De Sutter; Maxime Van Haeverbeke; Eva Van Braeckel; Stephanie Van Biervliet; Jan Van Bocxlaer; An Vermeulen; Elke Gasthuys
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-06-29

9.  What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?

Authors:  Rebecca J Calthorpe; Sherie J Smith; Nicola J Rowbotham; Paul A Leighton; Gwyneth Davies; Tracey Daniels; Katie Gathercole; Lorna Allen; Zoe C Elliott; Alan R Smyth
Journal:  BMJ Open Respir Res       Date:  2020-08

10.  Telehealth after the pandemic: Will the inverse care law apply? (Commentary).

Authors:  Rebecca J Calthorpe; Alan R Smyth
Journal:  J Cyst Fibros       Date:  2021-09-11       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.